Blackmores (ASX: BKL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Blackmores Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Blackmores (ASX: BKL)
    Latest News

    a woman
    ⏸️ Investing

    Blackmores Limited confirms strong growth: Is it a bargain?

    Natural health product developer, Blackmores Limited (ASX:BKL) has reiterated its strong growth following the company's most recent quarter.

    Read more »

    a woman
    ⏸️ Investing

    Blackmores Limited reports record half-year profit: Is it a bargain?

    Leading natural health product developer, Blackmores Limited (ASX:BKL) has reported a promising set of half-yearly results.

    Read more »

    a woman
    ⏸️ Investing

    Is it time to buy Blackmores Limited?

    Could Blackmores Limited (ASX:BKL) be a little expensive with the share price over $43? Here’s what you need to know:

    Read more »

    ⏸️ Investing

    Blackmores Limited profit tipped to jump 50% on last year's result: Should you buy?

    Although it’s an impressive jump, much of the benefits already seem to be priced in to Blackmores Ltd (ASX:BKL) shares.

    Read more »

    a woman
    ⏸️ Investing

    4 stocks soaring on the ASX today

    S&P/ALL Ordinaries closes flat, but these four jumped more than 11%

    Read more »

    a woman
    ⏸️ Investing

    3 stocks set to outperform in the year ahead

    Don’t miss out on future gains from Blackmores Limited (ASX:BKL), NIB Holdings Limited (ASX:NHF) and M2 Group Ltd (ASX:MTU).

    Read more »

    a woman
    ⏸️ Investing

    Stocks roaring to new highs: Should you buy these 2014 winners?

    It’s not too late get on board M2 Group Ltd (ASX:MTU) and Blackmores Limited (ASX:BKL).

    Read more »

    ⏸️ Investing

    Blackmores Limited profit growth appears unhealthy: More fish oil?

    1.8% growth in net profit appears aneamic

    Read more »

    a woman
    ⏸️ Investing

    5 best-of-the-best emerging growth stocks for your portfolio

    Smaller, emerging companies could be the key to outperformance in the current market.

    Read more »

    a woman
    ⏸️ Investing

    These 4 small caps could be the best kept secrets on the ASX

    Here’s why investors should aim to find stocks when there small and hang on while they grow.

    Read more »

    a woman
    ⏸️ Investing

    ARB Corporation Limited and Blackmores Limited set to shine

    Short-term setbacks make buying opportunities for long-term successful companies.

    Read more »

    Frequently Asked Questions

    Yes, Blackmores has historically paid two fully franked dividends a year. 

    Blackmores generally pays its shareholder dividends in April and September.

    Blackmores Ltd listed on the ASX on 2 May 1985.

    BKL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Blackmores

    Blackmores Ltd (ASX: BKL) is an Australian vitamin and health supplement manufacturer.

    The company was founded by Maurice Blackmore who opened Australia's first health food shop in Brisbane in 1932. Blackmores is now Australia's leading name in vitamin brands by market share.

    Overseas sales contribute a significant amount to the company's earnings, particularly from Southeast Asia where Blackmores products are sold in 13 markets.

    At its peak in 2018, around one-third of Blackmore's operating profit came from the Chinese market via both formal (cross-border e-commerce) and informal (daigou) sales channels. This revenue source has since dropped. In 2022, the company began selling its products in India.

    Blackmores Ltd (ASX: BKL) was delisted from the ASX on 11th Aug 2023.

     

     

     

     

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Stephen Patrick Roche Non-Executive Director Sep 2021
    Mr Roche has Senior executive/CEO experience in strategy (including customer and marketing), business development and supply chains across pharmacy, healthcare, retail and consumer markets. He has over 20 years' experience in Australian and New Zealand pharmacy markets, including serving as Deputy Chairman of the National Pharmaceutical Services Association.
    Ms Sharon Lee Warburton Non-Executive Director Apr 2021
    Ms Warburton has experience in corporate strategy, Australian and international business operations, finance, accounting, and risk management. Sharon has also been a part-time member of the Takeovers Panel since 2015.
    Ms Wendy Margaret Stops Non-Executive Director Apr 2021
    Ms Stops was Non-Executive Director with the Coles Group and Fitted for Work, Council Member of the University of Melbourne, Chair of the Industry Advisory Board for the Melbourne Business School's Centre for Business Analytics, Member of the Digital Experts Advisory Panel for the Department of Prime Minister and Cabinet's Digital Taskforce.
    Mr Alastair Symington Managing DirectorChief Executive Officer Sep 2019
    Mr Symington has more than 25 years of consumer goods experience in health and beauty across multiple geographies, spent 10 years with Nestle and Gillette in Australia, before joining Procter & Gamble (P&G) in 2006.
    Ms Erica Mann Non-Executive Director Sep 2021
    Mr Mann has experience with a 30 year career across multi-channel and multi-product environments. Erica chaired the board of the World SelfMedication Industry, a body that sets standards and guidelines for the design and labelling of non-prescription medicines and dietary supplements and held executive positions on the boards of South African Pharmaceutical Manufacturers' Association, Medicines Australia and the International Association of Infant Food Manufacturers.
    Ms Lyn Nikolopoulos Joint Company Secretary Oct 2022
    -
    Ms Helen Mediati Company Secretary Aug 2022
    -
    Patrick Gibson Chief Financial Officer
    -
    Cecile Cooper Chief Governance Officer
    -
    Kris Ellis Chief Information Officer
    -
    Joanne Smith Chief Marketing and Innovation Officer
    -
    Andrew Fuary Chief Operations Officer
    -
    Jane Franks Chief People Officer
    -
    Helen Mediati Company Secretary
    -
    Lesley Braun Director Blackmores Institute
    -
    Helen Mediati Group General Counsel
    -
    Lyn Nikolopoulos Joint Company Secretary
    -
    John Rosair Managing Director Australia and New Zealand and Global Pet
    -
    Kitty Liu Managing Director China
    -
    Dean Garvey Managing Director International
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 3,579,223 18.42%
    J P Morgan Nominees Australia Pty Limited 3,351,013 17.25%
    Marcus Blackmore 2,132,245 10.98%
    Citicorp Nominees Pty Limited 1,605,606 8.26%
    National Nominees Limited 781,058 4.02%
    Blackmore Foundation Pty Ltd <The Blackmore Foundation A/C> 696,535 3.59%
    BNP Paribas Noms Pty Ltd <Drp> 450,280 2.32%
    Estate Late Esther Whellan 150,347 0.77%
    Mrs Patricia Gladys Wright 123,912 0.64%
    Rathvale Pty Limited 113,088 0.58%
    Roy Shepherd 100,000 0.51%
    BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <Drp A/C> 66,763 0.34%
    Netwealth Investments Limited <Wrap Services A/C> 48,105 0.25%
    BNP Paribas Nominees Pty Ltd <Agency Lending Drp A/C> 38,809 0.20%
    Citicorp Nominees Pty Limited <Colonial First State Inv A/C> 37,588 0.19%
    Mr John Taylor 35,465 0.18%
    Powerwrap Limited <Escala Sma Trading A/C> 34,204 0.18%
    Ms Margaret Dittman 32,191 0.17%
    Mr Trevor Noel Praeger 31,660 0.16%
    Mrs Cheryl Elisabeth Henstridge 31,660 0.16%

    Profile

    since

    Note